Literature DB >> 8335927

Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1.

Y J Kim1, K E Pollok, Z Zhou, A Shaw, J B Bohlen, M Fraser, B S Kwon.   

Abstract

4-1BB is a 30-kDa inducible T cell Ag, and is expressed predominantly as a 55-kDa dimer on both CD4+ and CD8+ T lymphocytes. The cytoplasmic tail of 4-1BB contains the sequence Cys-Arg-Cys-Pro, which is similar to the sequence Cys-X-Cys-Pro, which mediates the binding of the CD4 and CD8 molecules to the protein tyrosine kinase p56lck. An anti-4-1BB mAb, 53A2, was used to determine whether 4-1BB may associate with p56lck. The 53A2 mAb specifically recognized 4-1BB on a CD8+ T cell line, CTLL-2, and coimmunoprecipitated a 56-kDa protein along with 4-1BB. Peptide mapping indicated that the 56-kDa phosphoprotein was identical to p56lck. The coimmunoprecipitation of p56lck with 4-1BB also occurred in nonlymphoid cells such as insect (Sf-21) and HeLa cells when the two recombinant proteins were coexpressed. Analysis of mutant p56lck recombinant proteins showed that two cysteine residues critical for p56lck-CD4 (or -CD8) complex formation are also required for the p56lck-4-1BB interaction. These studies establish that 4-1BB physically associates with p56lck.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335927

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  T-cell costimulatory blockade in organ transplantation.

Authors:  Jonathan S Maltzman; Laurence A Turka
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

2.  THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.

Authors:  Chuang Sun; Peishun Shou; Hongwei Du; Koichi Hirabayashi; Yuhui Chen; Laura E Herring; Sarah Ahn; Yang Xu; Kyogo Suzuki; Guangming Li; Ourania Tsahouridis; Lishan Su; Barbara Savoldo; Gianpietro Dotti
Journal:  Cancer Cell       Date:  2020-01-30       Impact factor: 31.743

3.  Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor.

Authors:  Hajime Nishimoto; Seung-Woo Lee; Hong Hong; Karen G Potter; Mari Maeda-Yamamoto; Tatsuya Kinoshita; Yuko Kawakami; Robert S Mittler; Byoung S Kwon; Carl F Ware; Michael Croft; Toshiaki Kawakami
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

4.  Immunotherapy targeting 4-1BB and its ligand.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

5.  Intrinsic signals in the unique domain target p56(lck) to the plasma membrane independently of CD4.

Authors:  M J Bijlmakers; M Isobe-Nakamura; L J Ruddock; M Marsh
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

Review 6.  Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.

Authors:  Robert S Mittler; Juergen Foell; Megan McCausland; Simona Strahotin; Liguo Niu; Abhijit Bapat; L Becker Hewes
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.

Authors:  M A DeBenedette; N R Chu; K E Pollok; J Hurtado; W F Wade; B S Kwon; T H Watts
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

8.  4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.

Authors:  W W Shuford; K Klussman; D D Tritchler; D T Loo; J Chalupny; A W Siadak; T J Brown; J Emswiler; H Raecho; C P Larsen; T C Pearson; J A Ledbetter; A Aruffo; R S Mittler
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

9.  The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.

Authors:  Isabel Barao
Journal:  Front Immunol       Date:  2013-01-04       Impact factor: 7.561

10.  Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells.

Authors:  Kamalakannan Rajasekaran; Pawan Kumar; Kristina M Schuldt; Erik J Peterson; Bart Vanhaesebroeck; Vishva Dixit; Monica S Thakar; Subramaniam Malarkannan
Journal:  Nat Immunol       Date:  2013-09-15       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.